THU032 Osilodrostat Is Effective And Well Tolerated In Patients Of Asian And Non-Asian Origin With Cushing's Disease: A Pooled Analysis From LINC 3 And LINC 4

Disclosure: P.J. Snyder: Consulting Fee; Self; Teva Pharmaceutical Industries Ltd. B.M. Biller: Consulting Fee; Self; HRA Pharmaceuticals, Recordati, Sparrow, Xeris Pharmaceuticals (Strongbridge). M. Fleseriu: Consulting Fee; Self; Recordati, Sparrow, Xeris Pharmaceuticals (Strongbridge), HRA Pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Snyder, Peter J, Biller, Beverly M K, Fleseriu, Maria, Pivonello, Rosario, Lee, Eun Jig, Leelawattana, Rattana, Kim, Jung Hee, Walia, Rama, Yu, Yerong, Liao, Zhihong, Piacentini, Andrea, Pedroncelli, Alberto M, Shimatsu, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Neuroendocrinology And Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555183/
http://dx.doi.org/10.1210/jendso/bvad114.1112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555183/
http://dx.doi.org/10.1210/jendso/bvad114.1112

Ejemplares similares